Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial infection refers to the process by which pathogenic microorganisms such as bacteria, viruses, fungi, or parasites invade host tissues, colonize, multiply, evade immune defenses, and cause disease, rather than a specific molecular entity like a receptor or enzyme. This multistage pathogenesis involves exposure, adhesion via structures like pili, invasion through virulence factors such as toxins and exoenzymes, and potential dissemination leading to local, focal, or systemic effects. Host defenses include innate barriers (e.g., skin, mucus, lysozyme), phagocytosis by macrophages and neutrophils, inflammation, and adaptive immunity with antibodies and T cells, but pathogens counter these via capsules, biofilms, immune evasion proteins, and intracellular survival. It is not a therapeutic target in the conventional sense—no single protein or gene is modulated by drugs—but rather a disease state targeted indirectly through antimicrobials that kill pathogens (e.g., antibiotics disrupting bacterial cell walls or protein synthesis) or host immunity enhancers like vaccines. Roles span numerous diseases including bacterial sepsis, viral illnesses, and opportunistic infections, with severity depending on pathogen virulence, host susceptibility, and transmission portals. Drug development focuses on pathogen-specific mechanisms, not "microbial infection" as a discrete target, making it unsuitable for precise therapeutic annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial infection.